Document is current
Any future updates will be listed below
-
Authors
Lu, Lei http://orcid.org/0000-0001-7097-1505
Riley, Nicholas M.
Shortreed, Michael R.
Bertozzi, Carolyn R. http://orcid.org/0000-0003-4482-2754
Smith, Lloyd M. http://orcid.org/0000-0002-6652-8639
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Howard Hughes Medical Institute
- License Information
-
More Information
Article History
Received: 18 May 2020
Accepted: 21 September 2020
First Online: 26 October 2020
Competing interests
: C.R.B. is a cofounder and Scientific Advisory Board member of Lycia Therapeutics, Palleon Pharmaceuticals, Enable Bioscience, Redwood Biosciences (a subsidiary of Catalent) and InterVenn Biosciences, and a member of the Board of Directors of Eli Lilly & Company.
